Apollo Endosurgery Inc.

NASDAQ: APEN · Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Apr 03, 2023, 10:00 PM

Apollo Endosurgery Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
76.86M 62.99M
Cost of Revenue
34.43M 28.03M
Gross Profit
42.43M 34.96M
Operating Income
-27.82M -19.2M
Interest Income
n/a n/a
Pretax Income
-39.26M -24.53M
Net Income
-39.84M -24.68M
Selling & General & Admin
56.59M 42.76M
Research & Development
11.91M 9.52M
Other Expenses
1.75M 1.88M
Operating Expenses
70.25M 54.16M
Interest Expense
4.67M 8.32M
Selling & Marketing Expenses
36.01M 24.31M
Cost & Expenses
104.68M 82.19M
Income Tax Expense
584K 156K
Shares Outstanding (Basic)
40.65M 30.24M
Shares Outstanding (Diluted)
40.65M 30.24M
EPS (Basic)
-0.98 -0.82
EPS (Diluted)
-0.98 -0.82
EBITDA
-31.42M -17.18M
EBIT
-34.58M -16.21M
Depreciation & Amortization
-196K 2.01M